Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs

Cristina Legnani; Michela Cini; Benilde Cosmi; Massino Filippini; Elisabetta Favaretto; Gualtiero Palareti

doi:10.1160/TH13-11-0925

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2014; 111(06): 1194-1196
DOI: 10.1160/TH13-11-0925

Letters to the Editor

Schattauer GmbH

Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs

Autoren

Cristina Legnani

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy
Michela Cini

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy
Benilde Cosmi

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy
Massino Filippini

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy
Elisabetta Favaretto

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy
Gualtiero Palareti

¹Department Angiology and Blood Coagulation “Marino Golinelli”, University Hospital S. Orsola-Malpighi, Bologna, Italy

Abstract

Volltext

Referenzen

References
1 de Moerloose P, Wutschert R, Heinzmann M. et al. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost 1998; 80: 239-241.
2 Hanson JN, Ascher E, De Pippo P. et al. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. J Vasc Surg 1998; 27: 677-680.
3 Martinelli I, Cattaneo M, Taioli E. et al. Genetic risk factors for superficial vein thrombosis. Thromb Haemost 1999; 82: 1215-1217.
4 Margaglione M, Brancaccio V, Ciampa A. et al. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilla centers: distinct roles in different clinical settings. Haematologica 2001; 86: 634-639.
5 de Godoy JM, Braile DM. Protein S deficiency in repetitive superficial thrombophlebitis. Clin Appl Thromb Hemost 2003; 09: 61-62.
6 Milio G, Siragusa S, Mina C. et al. Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins. Thromb Res 2008; 123: 194-199.
7 Milio G, Siragusa S, Malato A. et al. Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins. Int Angiol 2009; 28: 298-302.
8 Karathanos C, Sfyroeras G, Drakou A. et al. Superficial vein thrombosis in patients with varicose veins: role of thrombophilia factors, age and body mass. Eur J Vasc Endovasc Surg 2012; 43: 355-358.
9 de Godoy JM, Batigalia F, Braile DM. Superficial thrombophlebitis and anticardiolipin antibodies--report of association. Angiology 2001; 52: 127-129.
10 Legnani C, Palareti G, Guazzaloca G. et al. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Eur Heart J 2002; 23: 984-990.
11 Legnani C, Cosmi B, Cini M. et al. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 2004; 124: 504-510.
12 Desmarais S, De Moerloose P, Reber G. et al. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347: 1374-1375.
13 Manten B, Westendorp RGJ, Koster T. et al. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thromb Haemost 1996; 76: 510-513.
14 Martinelli I, Cattaneo M, Panzeri D. et al. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 1997; 77: 440-443.
15 Van den Broucke JP, Bertina RM, Holmes ZR. et al. Factor V leiden and fatal pulmonary embolism. Thromb Haemost 1998; 79: 511-516.
16 Decousus H, Epinat M, Guillot K. et al. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med 2003; 09: 393-397.
17 Decousus H, Quere I, Presles E. et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med 2010; 152: 218-224.
18 Cesarone MR, Belcaro G, Agus G. et al. Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. Angiology 2007; 58: 7S-14S.
19 Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA project. Thromb Haemost 1997; 78: 636-640.
20 De Stefano V, Chiusolo P, Paciaroni K. et al. Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost 1998; 24: 367-379.
21 Rosendaal FR, Doggen CJM, Zivelin A. et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-708.
22 Tosetto A, Missiaglia E, Frezzato M. et al. The VITA Project: Prothrombin G20210A mutation and venous thromboembolism in the general population. Thromb Haemost 1999; 82: 1395-1398.
23 Pernod G, Biron-Andreani C, Morange PE. et al. Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 2009; 34: 156-203.
24 Schonauer V, Kyrle PA, Weltermann A. et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg 2003; 37: 834-838.